MARCKS is a widely expressed protein kinase C substrate that is essential for normal prenatal development of the central nervous system in mice. MARCKS-deficient mice exhibit universal perinatal mortality and numerous developmental abnormalities of the brain and retina. To determine which domains of the protein were important in complementing these neurodevelopmental anomalies, we have interbred MARCKS knockout mice with transgenic mice expressing an epitope-tagged human MARCKS transgene that can completely correct the MARCKS-deficient phenotype. Previous structure-function studies showed that a nonmyristoylatable form of MARCKS could correct all of the neuroanatomical abnormalities, and resulted in approximately 25% viable pups that grew to adulthood and were fertile. The present experiment attempted a similar complementation strategy in which a nonmyristoylatable, ''pseudo-phosphorylated'' form of the protein was used, which has been shown to be almost completely cytosolic in cell expression studies. Surprisingly, this transgene was able to complement almost all of the cerebral anatomical abnormalities characteristic of the knockout mice. However, these mice also exhibited a universal, novel phenotype: profound retinal ectopia, in which retinal tissue was often found in the vitreous humor as well as extraocularly. Retrospective evaluation of the original MARCKS knockout phenotype revealed that this anomaly was present in about 43% of the knockout mice, and was clearly detectable as early as embryonic day 12.5, before retinal cell differentiation begins. These data suggest that a nonmyristoylatable, pseudo-phosphorylated form of MARCKS can complement most if not all cerebral aspects of the MARCKS-deficient phenotype, but that it appears to worsen a retinal phenotype, perhaps by exerting a dominant-negative effect on a coexpressed MARCKS homologue.
INTRODUCTION
The myristoylated alanine-rich C kinase substrate (MARCKS), a prominent cellular substrate of protein kinase C (PKC), is an acidic, heat-stable protein with three highly conserved domains: a myristoylation consensus sequence following the glycine residue at position 2 in the amino terminus; the site of intron splicing; and the phosphorylation site domain (PSD), which contains three or four serines that are the only residues known to be phosphorylated by PKC (reviewed in Aderem, 1992; Blackshear, 1993) . The PSD has been shown to interact with calmodulin (Graff et al., 1989; McIlroy et al., 1991) , actin (Hartwig et al., 1992) , cathepsin B (Spizz and Blackshear, 1997) , and cellular membranes (Kim et al., 1994a,b; Blackshear, 1995, 1996) ; in all cases, these interactions are inhibited by phosphorylation of MARCKS by PKC. Although the exact function of MARCKS in cells has not been determined, previous studies in cell-free systems, intact cells and intact animals have implicated both the PSD and the amino terminal myristate moiety in the plasma membrane association of the protein (Kim et al., 1994a,b; Blackshear, 1995, 1996; .
Studies in mice in which the gene encoding MARCKS (Macs) was disrupted showed that MARCKS expression was essential for the normal development of the central nervous system and postnatal survival (Stumpo et al., 1995; Blackshear et al., 1996 Blackshear et al., , 1997 . These mice exhibited several gross abnormalities of the central nervous system, including failure of fusion of the cerebral hemispheres, agenesis of the corpus callosum and other forebrain commissures, defects in cortical and retinal lamination, and neuronal leptomeningeal ectopia, as well as high frequencies of exencephaly. More recently, we have shown that these anatomical defects could be completely complemented by the transgenic expression of epitope-tagged human MARCKS, driven by 3.4 kb of human MACS promoter, in the Macs (Ϫ/Ϫ) mice . We also showed that the transgenic expression of a nonmyristoylated form of human MARCKS, in which the glycine in the 2 position was mutated to an alanine (A 2 /G 2 mutation), surprisingly resulted in the apparent correction of all of the anatomical defects characteristic of the Macs (Ϫ/Ϫ) mice and resulted in a 25% postnatal survival rate .
The purpose of the present studies was to further investigate this ''structure-function'' paradigm by attempting to rescue the Macs (Ϫ/Ϫ) mice with a transgene consisting of the identical human MACS gene to those described above, except that the amino terminal glycine was mutated to alanine (A 2 /G 2 ), preventing myristoylation, and the four serines in the PSD were mutated to aspartic acid residues (D/S), to electrostatically mimic the maximally phosphorylated state of the protein. In contrast to the wild-type protein, or MARCKS in which either but not both of these mutations was present, this ''double-mutant'' MARCKS was almost exclusively cytosolic in intact cell studies , and exhibited much weaker affinity for cellular membranes in cell-free assays (Swierczynski and Blackshear, 1995) . We show here that, although all of the Macs (Ϫ/Ϫ) mice expressing the doublemutant transgene died in the perinatal period, surprisingly, all of the known anatomical defects seen in the brains of the knockout mice were corrected. However, we also noted the appearance of a novel phenotype in 100% of the knockout mice expressing the double-mutant transgene, in which retinal tissue was ectopically located in the vitreous humor and elsewhere. This abnormality was found in about 43% of the Macs (Ϫ/Ϫ) mice without a transgene. These data suggest that a ''pseudo-phosphorylated,'' nonmyristoylated form of MARCKS, which has a much lower than normal affinity for cellular membranes, may simultaneously correct some of the anatomical defects of the Macs (Ϫ/Ϫ) phenotype while worsening others, perhaps through a dominant negative effect on a normally expressed MARCKS homologue, the MARCKS-like protein (MLP).
MATERIALS AND METHODS

Construction of Transgenic Vector MACS(A2/G2)D/S-12CA5
The starting clone for this mutant transgenic vector was the plasmid MACS(A2/G2)-12CA5 . This 7.5-kb insert in Bluescribe (Stratagene, La Jolla, CA) contains a portion of the originally described human gene encoding MARCKS (MACS; Harlan et al., 1991) consisting of about 3.4 kb of the MACS 5Ј-flanking region, the entire coding region and single intron, and 0.6 kb of 3Ј-flanking region. The native human MARCKS protein coding sequence had been modified to contain a nine-amino-acid epitope tag derived from influenza virus hemagglutinin (Kolodjiej and Young, 1991) , inserted five amino acids from the carboxyl terminus; this epitope-tagged human construct has been shown to completely complement the MARCKS-deficiency phenotype in mice . In addition, the amino terminal glycine (G 2 ) had been mutated to alanine (A 2 ) to prevent cotranslational myristoylation.
For the current study, this parent plasmid was further modified so that the four serines in the phosphorylation site domain (Blackshear, 1993) were mutated to aspartic acid residues, in order to mimic electrostatically the fully phosphorylated state of the protein (pseudo-phosphorylated MARCKS). This was carried out using the Altered Sites oligonucleotide-directed in vitro mutagenesis kit from Promega (Madison, WI). Correctly mutated sequences were confirmed by dideoxy sequencing (Sanger et al., 1977) . This double mutant, (A 2 /G 2 ) D/S, has been shown previously to be almost completely cytosolic in cell-free systems and in intact cells, in contrast to the plasma membrane association of most of the wild-type protein Blackshear, 1995, 1996) . All other methods, including the generation and characterization of the transgenic mice, including the MARCKS-and MLP-␤-galactosidase-expressing mice, interbreeding with Macs (Ϫ/Ϫ) mice, subcellular fractionation, routine histology, immunohistochemistry, and routine Northern, Southern, and Western blotting, were performed as described previously Blackshear et al., 1997; Stumpo et al., 1998) .
RESULTS
Subcellular Distribution of the Double Mutant MARCKS Protein
Three lines of transgenic mice expressing the vector MACS(A2/G2)D/S-12CA5 (hereafter known as the ''doublemutant''), were evaluated by Southern, Northern, and Western blotting of various tissues, and one line with high-level expression of the mutant protein was chosen for interbreeding with the Macs (ϩ/Ϫ) mice. The level of expression of the transgenic MARCKS protein in the transgenic Macs (ϩ/ϩ) mice was approximately 2.2-fold that of the endogenous protein in the brains of these mice, as determined by quantitative Western blotting of brain homogenates from three mice with an antibody directed at the highly conserved amino terminal peptide of the protein (Lobaugh and Blackshear, 1990; not shown) . No abnormalities were noted in these transgenic mice, in size, weight, breeding behavior, or gross morphology of tissues and detailed histology of brain and retina. When brains of adult mice from this line were evaluated for subcellular distribution of the mutant MARCKS protein and compared to brains from a similar line of mice expressing the epitope-tagged, wild-type human protein, 45 Ϯ 13% (mean Ϯ SD) of double-mutant MARCKS was present in the high-speed supernatant or cytosolic fraction, compared to only 8 Ϯ 1% of the wildtype protein (P ϭ 0.004 using Student's t test; n ϭ 3 in each group). Similar results were observed with the endogenous mouse protein (not shown).
The subcellular distribution of the double-mutant protein was also analyzed by immunohistochemistry of the developing neural tube at E9.5, when it is possible to see the plasma membrane distribution of wild-type MARCKS by staining for either the native protein or the epitope-tagged transgene Blackshear et al., 1996) . As shown in Fig. 1 , the wild-type epitope-tagged protein was almost exclusively associated with the plasma membrane under these conditions. The double-mutant protein was also membrane-associated to a large extent, but its distribution appeared to be greater in the cytosol than that of the wild-type protein. Parallel immunostaining of an E9.5 mouse embryo not expressing an epitope-tagged version of MARCKS gave no visible staining under identical conditions in the same experiment ( Fig. 1) .
Phenotype of Macs (؊/؊) Mice Expressing the Double-Mutant MARCKS Protein
We have shown previously that Macs (Ϫ/Ϫ) mice expressing the wild-type human protein appeared to be completely normal, and that knockout mice expressing the single mutant (A 2 /G 2 ) MARCKS had about 75% perinatal mortality, were slightly smaller than normal, but had phenotypically normal brains and retinas, at least compared to the gross disruption of central nervous system structures that characterize the Macs (Ϫ/Ϫ) phenotype (Stumpo et al., 1995; Blackshear et al., 1997) . We attempted the same type of ''rescue'' experiment with the transgenic mice expressing the double-mutant. When Macs (Ϫ/Ϫ) mice expressed the double-mutant transgene at levels comparable to or higher than the wild-type transgene that was successful in rescuing the null phenotype, 100% of the newborn mice also died at about the time of birth, as was true of the original Macs (Ϫ/Ϫ) mice (Stumpo et al., 1995) .
However, the double-mutant transgene expression appeared to completely correct the gross anatomical abnormalities seen in the brains of the Macs (Ϫ/Ϫ) mice. As shown in Fig. 2 , the MARCKS knockout mice expressing the double-mutant transgene had normal anterior cerebral hemisphere fusion, normal forebrain commissures, including the corpus callosum, and apparently normal lamination patterns of the forebrain cortex. In particular, the severe and widespread leptomeningeal neuronal ectopia characteristic of the Macs (Ϫ/Ϫ) mice , reflected in a grossly disordered pattern of outer cortical synaptophysin staining, was not seen in the double-mutant-expressing FIG. 1. Subcellular localization of wild-type and double-mutant MARCKS in the neural tube at E9.5. Transgenic embryos expressing either wild-type (A) or double mutant (B) MARCKS were prepared for frozen section immunohistochemistry with the antibody to the epitope tag and a fluorescein-conjugated second antibody. The control ( C ) was a nontransgenic embryo of identical age. Each section was 10 m in thickness, and is of a portion of the cranial neural tube in each case. Film exposures were identical (5 s) in each case; however, the developer exposure in A was slightly longer than in B and C because of the lower level of expression of the wild-type transgene. Other controls in which each section was treated identically without the primary antibody were completely negative for immunoreactivity (not shown). Bar, 10 m.
Macs (Ϫ/Ϫ) mice (Fig. 3) . Finally, we have not seen either exencephaly or omphalocele in the animals ''rescued'' by the double-mutant transgene; both of these abnormalities are common in the Macs (Ϫ/Ϫ) mice (Stumpo et al., 1995) . Thus, the cause of perinatal death in these animals is not obviously due to a grossly disordered central nervous system, as was presumed in the original knockout animals, and remains unknown.
The retinas of the MARCKS-deficient mice exhibited an interesting phenotype in that the normal lamination patterns seen at the time of birth were disrupted (Stumpo et al., 1995; see below) . This characteristic phenotype included a near absence of the normally well-demarcated, largely acellular inner plexiform layer between the inner and outer nuclear layers (see below). This phenotype was universal in the MARCKS-deficient mice (Stumpo et al., 1995) .
In the present studies, expression of the double-mutant transgene restored this layer to its normal thickness (Figs. 2 and 4). However, this was accompanied by a new and entirely unexpected phenotype: The appearance of ectopically located retinal tissue, generally in the vitreous humor (Figs. 2 and 4) . This abnormality was seen in all of the double-mutant-expressing Macs (Ϫ/Ϫ) mice examined. In other instances, extraocular retinal tissue and partially duplicated retinas were found (data not shown). This condition, which we will call ''retinal ectopia,'' ranged from multiple, widespread deposits of retinal cells in the vitreous humor, in many cases with rudimentary maintenance of cell laminations (Figs. 4A and 4B) , to a single instance of abnormal retinal folding in one mouse (Fig. 4 I) . The other tissues of the eye, including the lens, optic nerve, skin over the eye, etc. appeared to be normal except when disturbed by the ectopically located retinal tissue (Fig. 4) . In addition, normal differentiation of retinal cells appeared to be present, even in the ectopically located tissue (Fig. 4) .
Because of these results, we examined retinas from eight Macs (ϩ/Ϫ) mice that expressed the transgene; these were all normal (see also Fig. 5 ). We also reanalyzed retinal sections from 35 of the original Macs (Ϫ/Ϫ) mice, i.e., without transgene expression. Fifteen (43%) of these animals exhibited similar retinal ectopia; this abnormality was readily discerned as early as E12.5 (Fig. 6 ), before retinal cell differentiation begins at about E13 (Young, 1983) . Thus, a high frequency of retinal ectopia appears to be part of the original MARCKS- deficiency phenotype. Remarkably, however, this was present in 100% of the double-mutant-rescued knockout mice, despite normalization of the other aspects of the phenotype, including normal thickness of the inner plexiform layer, by the expression of the double-mutant transgene.
Several additional studies were performed in an attempt to determine the proximate cause of the retinal ectopia. At E9.5, the optic vesicles in the knockout embryos appeared normal histologically and by scanning electron microscopy; they also displayed normal patterns of expression of chondroitin sulfate proteoglycans and laminin . However, profound abnormalities could be seen as early as E12.5 (Figs. 6J-6L), before significant retinal cell differentiation is present in the mouse. In many cases, the eyes at E12.5 demonstrated close juxtaposition between a portion of the retina and the lens capsule (Figs. 6J-6L ), raising the possibility of abnormal adhesion between a portion of the retina and the lens as the cause of the ectopia. No abnormalities in the expression of a number of adhesion and matrix molecules were noted at that stage, including chondroitin sulfate proteoglycans, phosphacan, tenascin, or N-CAM (data not shown).
At later developmental stages, the impression of adhesion between the retina and lens capsule was stronger, at E14.5 (Figs. 6F-6H ) and E18.5 (Figs. 6B-6D) . However, not all of the abnormalities could be explained by continued adhesion between the lens and retina; for example, Fig. 6C shows a retinal fold in what appears to otherwise be a normal retina, without apparent lens adhesions. Such exuberant retinal growth could be due to increased cell proliferation; however, staining for proliferating cell nuclear antigen (Greenwell et al., 1991) revealed no evidence for increased numbers of proliferating cells in the retinas of the knockout mice (not shown).
In cases of the most extreme retinal disruption, as in Fig.  6D , retinal cells adhered to the lens capsule at many locations. In such severe cases, a variety of retinal cells could be found in the vitreous, including postmitotic cells staining for synaptophysin, pyknotic nuclei and other cell debris, and even cells from the pigment epithelium. We stained such abnormal retinas for the presence of excess apoptosis, and for inflammatory cells; however, the level of cellular apoptosis was similar to that seen in control retinas, and no inflammatory cells were present.
Normal Expression of MARCKS and MLP in the Mouse Retina
These studies prompted us to evaluate the normal distribution of MARCKS and MLP in the retina of mice during development. As illustrated in Fig. 7B , MARCKS is very highly expressed in all cells of the retina at E18.5 in the normal fetal mouse, with particularly high-level expression in the anuclear regions of the inner plexiform layer and the optic nerve layer immediately adjacent to the vitreous humor (Fig. 7B) . Although MARCKS is also highly expressed in the cerebral cortex, the expression in the retina is much greater at this date, as determined by comparative immunostaining of these tissues in the same experiment (Figs. 7A and 7B) .
High-level expression of both MARCKS and MLP mRNA in the retina has previously been demonstrated (Stumpo et al., 1998) . Retinal expression of the MARCKS transgene used in these studies was also very high, as evidenced by expression of a MARCKS-␤-galactosidase transgene that used the same length of MACS promoter as that used in the present experiments (Fig. 8) . In similar studies using a comparable MLP-␤-galactosidase fusion protein (Stumpo et al., 1998) , retinal expression of the two fusion proteins was very similar, with high level expression observed in essentially all of the undifferentiated retinal cells and optic nerve at E12.5, and high level expression in the inner plexiform layer, the inner nuclear (ganglion cell) layer and optic nerve fiber layer at E15.5 (Fig. 8) .
DISCUSSION
In our previous attempts to perform structure-function analysis of the MARCKS protein by the transgenic rescue of MARCKS-deficient mice, we showed that expression of epitope-tagged human MARCKS completely prevented the 
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severe neuroanatomical defects characteristic of the Macs (Ϫ/Ϫ) phenotype . In addition, we showed that expression of a nonmyristoylatable form of the protein, the A 2 /G 2 mutant, could partially complement the null phenotype: approximately 25% of the animals survived, and, although slightly smaller than normal, the adults had anatomically normal brains and retinas .
The present studies extend these results by attempting to complement the null phenotype with the transgenic expression of the double-mutant MARCKS. This mutation has been shown previously to result in a protein that exhibits negligible affinity for fibroblast membranes in a cell-free assay, compared to avid binding of the wild-type protein (Swierczynski and Blackshear, 1995) . Similarly, when wildtype and mutant human MARCKS were expressed in REF52 rat fibroblasts, only 0.8% of the double-mutant protein was found bound to a crude cell membrane fraction, compared to 82% of the wild-type protein . Very similar data were obtained when chicken MARCKS was expressed in human 293 cells: About 80% of the wild-type protein was associated with the membranes, compared to 2% of the double-mutant protein. The plasma membrane localization of the wild-type protein was confirmed by immunoelectron microscopy .
Based on the data from these previous studies, we expected the double-mutant form of MARCKS to have negligible affinity for membranes when expressed in intact mice. At least in mouse brain, this did not seem to be the case. For example, simple fractionation of brain into crude membrane and cytosolic fractions by high-speed centrifugation revealed that about 55% of the double-mutant protein was found in the membrane fraction compared to 92% of the wild-type protein. Similarly, immunohistochemical staining of the neural tube at E9.5, when MARCKS staining of plasma membranes can be clearly visualized , showed that the double-mutant protein was expressed to a greater extent in the cytosol than the wild-type endogenous protein, but a substantial fraction of the protein still appeared to be associated with the plasma membrane. In contrast to the previous experiments in stable cell lines, therefore, the double-mutant protein still was capable of appreciable plasma membrane association in the neural tube and brain of intact animals. One interesting possibility raised by these results is that, when doublemutant MARCKS is expressed under more physiological conditions than in the cultured cell studies, i.e., in the cell types in intact tissues that normally express high levels of the protein and in which it is critical for normal development, other mechanisms of maintaining membrane association may be operative. These could include continued binding to the lipid bilayer mediated by other domains of the protein, or perhaps interactions with other membrane or cortical proteins that persist despite the presence of the two mutations.
These results may help to explain the rather surprising
FIG. 7. Endogenous MARCKS expression in fetal mouse retina.
Tissues from a Macs (ϩ/ϩ) mouse at E18.5 were fixed and embedded in paraffin, and immunostained for endogenous mouse MARCKS. The three tissues shown are outer forebrain cerebral cortex (A), retina (B), and the cartilage primordium of the presphenoid bone (C). The light color indicates antibody staining (fluorescence). In all three cases, photographic exposure was the same (15 s), and developer exposure was the same. Since all three tissues were stained in parallel, the amount of fluorescence shown is directly proportional to the amount of MARCKS expressed in the tissue. In A, cp, cortical plate; mz, marginal zone; bl, basal lamina; pm, pia mater. In B, onl, outer nuclear layer; inl, inner nuclear layer; arrow, inner plexiform layer; v, vitreous humor. In C, the arrow points to a thin layer of surface cells that are MARCKS positive in the otherwise negative cartilage. Bar, 25 m.
finding that this double-mutant protein was able to complement many of the anatomical defects in the brain that characterize the Macs (Ϫ/Ϫ) phenotype. The following abnormalities were corrected: exencephaly; omphalocele; agenesis of the corpus callosum and other forebrain commissures; neuronal leptomeningeal ectopia, with grossly aberrant synaptophysin staining; and near absence of the inner plexiform layer of the retina. Despite these anatomical corrections, the double-mutant-expressing knockout mice had a 100% perinatal mortality. It is possible that this universal mortality resulted from a defect in MARCKS signaling due to its unvarying, pseudo-phosphorylated state. Experiments are currently in progress in which expression of the normally myristoylated tetra-asp and tetraasn proteins is used to complement the null phenotype; these studies may help to answer the question about the PKC-dependent signaling function of the protein. However, it is clear that the simple presence of normal MARCKS sequences in the knockout mice is not by itself sufficient to complement the null phenotype, since transgenic expression of wild-type MARCKS linked to ␤-galactosidase in a fusion protein does not complement any of the Macs (Ϫ/Ϫ) phenotypic abnormalities, despite abundant expression (W. S. Lai and P. J. Blackshear, unpublished data) . Since all of the cerebral anatomical abnormalities of the MARCKS-deficient mice were corrected in the knockout mice expressing the double-mutant transgene, we were surprised to note the presence of a new phenotype in 100% of these animals: retinal ectopia. This striking abnormality varied from simple and apparently single retinal folds to widespread vitreous fragments of retinal tissue to extraocular retina development, despite the apparent normalization of the thickness of the inner plexiform layer in the same eyes. This abnormality has not been seen in any of the Macs (ϩ/ϩ) or (ϩ/Ϫ) mice analyzed, nor was it present in the transgenic mice expressing the double-mutant protein on a Macs (ϩ/ϩ) or (ϩ/Ϫ) background. Similar abnormalities have been found in association with microphthalmia, which can occur in as many as 4 -10% of C57BL mice (Smith et al., 1994) ; similarly, mice in which lens formation FIG. 8. MARCKS-␤-galactosidase and MLP-␤-galactosidase fusion protein expression in transgenic fetal mouse retinas. Patterns of retinal MARCKS-and MLP-␤-galactosidase expression were evaluated in fetal transgenic mice, with the blue color indicating ␤-galactosidase staining, and the pink color the fast-red counterstain. A, MARCKS-␤-galactosidase staining at E12.5; B, MARCKS-␤-galactosidase staining at E15.5; C, MLP-␤-galactosidase staining at E12.5; D, MLP-␤-galactosidase staining at E15.5. In A and C, the retinal cells are undifferentiated and uniformly and heavily stained, as is the optic nerve. In B and D, the inner plexiform layer, the outer nuclear (ganglion cell) layer and the optic nerve fiber layer are all more heavily stained than the outer nuclear (ventricular cell) layer.
has been disrupted by mutation or retinal expression of a toxin also exhibited retinal folding and other retinal abnormalities (Zwan and Webster, 1984; Landel et al., 1988; Breitman et al., 1989) . However, both eye size and lens development appeared remarkably normal in the present studies, even when the retina was grossly disordered.
These results prompted us to reexamine the retinal morphology of the Macs (Ϫ/Ϫ) mice, in which we had previously described the only retinal abnormality as a near-absence of the inner plexiform layer (Stumpo et al., 1995) . By examining many sections of eyes from these mice, we found a frequency of retinal ectopia of about 43% (15 of 35 mice examined). In general, this appeared to be less severe than the universal ectopia observed in the doublemutant rescued mice described here. However, occasional instances of more severe ectopia, including vitreous retinal ''islands,'' as well as extraocular and partially duplicated retina, were observed in a few of the animals. We found clear instances of this abnormality in mice as early as E12.5, before any retinal cell differentiation occurs (Young, 1983) ; in addition, the appearance of the retinal cells, and their state of differentiation, appeared to be normal, despite their ectopic locations. Thus, it seems unlikely that this abnormality is due to either retinal cell differentiation or migration, since both appeared to be occurring normally in unaffected areas, and as normally as possible in affected areas. Instead, it appears that the abnormality is due to an error early in eye development. The many instances of incomplete separation of the retina and lens suggest the possibility that the lens pit and neural layer of the optic cup fail to separate normally at E9 -11 (Kaufman, 1979) , a time when both MARCKS and MLP (Wu et al., 1996; Chen et al., 1996; Stumpo et al., 1998) are highly expressed in the developing neural tube.
How can we explain the effects of an expressed mutant transgene that simultaneously corrects most of the abnormalities characteristic of the Macs (Ϫ/Ϫ) phenotype, while apparently making worse a single aspect of the phenotype? One possibility is that the double-mutant form of the protein is exerting a dominant-negative effect on normal compensatory expression of the MARCKS homologue, the MARCKS-like protein or MLP. This speculation is supported by several indirect lines of evidence. First, MLP is very highly expressed in the brain and retina of fetal mice, and is highly expressed in the neural tube from about E8 onward (Stumpo et al., 1995; Wu et al., 1996; Chen et al., 1996; Stumpo et al., 1998) . In addition, the expression patterns of MARCKS and MLP in the developing retina are very similar, as shown here, with high-level expression of both proteins in essentially all of the undifferentiated retinal cells at E12.5. Previous studies with mutant forms of MLP, which lacked a phosphorylation site domain, have suggested that the mutant could exert dominant-negative influences on macrophage behaviors such as phagocytosis (Zhu et al., 1995; Li et al., 1996) . We showed by comparative immunohistochemistry in the present work that MARCKS is very highly expressed in the retina compared to the next greatest site of expression, the forebrain cortex. Since the double-mutant transgene is driven by normal MARCKS promoter elements and is very highly expressed in the retina (Stumpo et al., 1998; this paper) , it is possible that in this tissue the transgenic protein is exerting a dominant-negative effect by interfering with the action of other ''MARCKS equivalents,'' represented in this case by MLP. The effects of Mlp knockout on the retina were not commented on in one report, in which the mice exhibited universal exencephaly ; in another report, survival to adulthood without neural tube defects was fairly common, and the retinal morphology of these surviving mice was described as ''thinner and compressed . . . , although the overall layered structure was not altered'' (Wu et al., 1996) . If the apparent deleterious effects of the doublemutant protein on the retina seen in the present study are due to a dominant-negative effect of the mutant protein, this would predict that a MARCKS/MLP double knockout would have universal and perhaps severe retinal ectopia. However, since these animals are likely to have very severe defects in neural tube formation and perhaps universal exencephaly, it may be difficult to determine the effect of this double knockout on retinal development.
